Analytical performance of a sensitive assay for cardiac troponin I with loci™ technology

Clinical Biochemistry

Volumn 43, Issue 12, 2010, Pages 998-1002

  Arrebola, M M ^a   Lillo, J A ^a   Diez De Los Rios M J ^a   Rodriguez M ^a   Dayaldasani, A ^a   Yahyaoui, R ^a   Perez V ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Acute coronary syndrome; LOCI technology; Troponin I

Indexed keywords

REAGENT; TROPONIN I; RHEUMATOID FACTOR;

ACUTE CORONARY SYNDROME; ANALYZER; ARTICLE; ASSAY; BLOOD SAMPLING; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; LUMINESCENCE; LUMINESCENT OXYGEN CHANNELING IMMUNOASSAY; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; RISK ASSESSMENT; SERUM; SPECTROPHOTOMETRY; ADOLESCENT; ADULT; AGED; BIOASSAY; BLOOD; FEMALE; LIMIT OF DETECTION; MALE; MIDDLE AGED; PROCEDURES; REPRODUCIBILITY; YOUNG ADULT;

ACUTE CORONARY SYNDROME; ADOLESCENT; ADULT; AGED; BIOLOGICAL ASSAY; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RHEUMATOID FACTOR; TROPONIN I; YOUNG ADULT;

EID: 77954309258     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.04.073     Document Type: Article

References (39)

1. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
2. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001, 141:190-199. GRACE Investigators.
3. Birkhead J.S., Walker L., Pearson M., Weston C., Cunningham A.D., Rickards A.F. Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart 2004, 90:1004-1009.
4. Rapezzi C., Biagini E., Branzi A. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2008, 29(2):277-278.
5. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Eur Heart J 2007, 28(20):2525-2538. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction.
6. Apple F.S., Jesse R.L., Newby L.K., Wu A.H., Christenson R.H., National Academy of Clinical Biochemistry, et al. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007, 115(13):e352-e355.
7. Morrow D.A., Cannon C.P., Jesse R.L., Newby L.K., Ravkilde J., Storrow A.B., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 2007, 115(13):e356-e375.
8. Panteghini M. Performance of today's cardiac troponin assays and tomorrow's. Clin Chem 2002, 48:809-810.
9. Apple F.S., Parvin C.A., Buechler K.F., Christenson R.H., Wu A.H.B., Jaffe A.S. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005, 51:2198-2200.
10. Poulsen F., Jensen K.B. A luminescent oxygen channel immunoassay for the determination of insulin in human plasma. J Biomol Screen 2007, 12:240-247.
11. Liu Y.P., de Keczer S., Alexander S., et al. Homogeneous, rapid luminescent oxygen channeling immunoassay (LOCI™) for homocysteine. Clin Chem 2000, 46:1506-1507.
12. Ullman E.F., Kirakossian H., Switchenko A.C., et al. Luminescent oxygen channeling assay (LOCI™): sensitive, broadly applicable homogeneous immunoassay method. Clin Chem 1996, 42:1518-1526.
13. Kelley W.E., Lockwood C.M., Cervelli D.R., et al. Cardiovascular disease testing on the Dimension Vista® system: biomarkers of acute coronary syndrome. Clin Biochem 2009, 42:1441-1451.
14. Protocols for determination of limits of detection and limits of quantitation; approved guideline. NCCLS guideline EP17-A October 2004, Clinical and Laboratory Standards Institute, NCCLS, Wayne, PA.
15. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. NCCLS guideline EP6-A April 2003, Clinical and Laboratory Standards Institute, NCCLS, Wayne, PA.
16. Evaluation of precision performance of quantitative measurement methods; approved guideline. NCCLS guideline EP5-A2 August 2004, Clinical and Laboratory Standards Institute, NCCLS, Wayne, PA.
17. Method comparison and bias estimation using patient samples; approved guideline. NCCLS guideline EP9-A2 September 2002, Clinical and Laboratory Standards Institute, NCCLS, Wayne, PA.
18. Interference testing in clinical chemistry; approved guideline - second edition. NCCLS guideline EP7-A2 November 2005, Clinical and Laboratory Standards Institute, NCCLS, Wayne, PA.
19. Ulman E.F., Kirakossian H., Singh S., et al. Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc Natl Acad Sci 1994, 91:5426-5430.
20. Kroll M.H., Praestgard J., Michaliszyn E., Styer P. Evaluation of the extent of nonlinearity in reportable range studies. Arch Pathol Lab Med 2000, 124:1331-1338.
21. Wu A.H.B., Lu Q.A., Todd J., Moecks J., Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice. Clin Chem 2009, 55:52-58.
22. Passing H., Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983, 21:709-720.
23. Kavsak P.A., MacRae A.R., Yerna M.J., Jaffe A.S. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 2009, 55:573-577.
24. Dati F., Panteghini M., Apple F.S., Christenson R.H., Mair J., Wu A.H. Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays. Scand J Clin Lab Invest 1999, 59(Suppl 230):113-123.
25. Wu A.H., Feng Y.J., Moore R., et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization. Clin Chem 1988, 44:1198-1208.
26. Katrukha A.G., Bereznikova A.V., Filatov V.L., et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998, 44:2433-2440.
27. James S., Flodin M., Johnston N., Lindahl B., Venge P. The antibody configurations of cardiac troponin I assays may determine their clinical performance. Clin Chem 2006, 52:832-837.
28. Le Moal E., Giulani I., Bertinchant J.P., Polge A., Larue C., Villard-Saussine S. Earlier detection of myocardial infarction by an improved cardiac TnI assay. Clin Biochem 2007, 40:1065-1073.
29. Bodor G.S., Porter S., Landt Y., Ladenson J.H. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992, 38(11):2203-2214.
30. Adams J.E., Bodor G.S., Dávila-Román V.G., et al. Cardiac troponin-I: a marker with high specificity for cardiac injury. Circulation 1993, 88(1):101-106.
31. Adams J.E., Sicard G.A., Allen B.T., et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin-I. N Engl J Med 1994, 330(10):670-674.
32. www.ifcc.org/ScientificActivities/Committees/C-SMCD/cTn_Assay_Table_v091209.pdf.
33. Ullman E.F., Kirakossian H., Switchenko A.C., et al. Luminescent oxygen channeling assay (LOCI™): sensitive, broadly applicable homogeneous immunoassay method. Clin Chem 1996, 42:1518-1526.
34. Liu Y.P., Keezer S., Alexander S., et al. Homogeneous, rapid luminescent oxygen channeling immunoassay (LOCI™) for homocysteine. Clin Chem 2000, 46:1506-1507.
35. Poulsen F., Jensen K.B. A luminescent oxygen channeling immunoassay for the determination of insulin in human plasma. J Biomol Screen 2007, 12:240-247.
36. Panteghini M. Recent approaches to the standardization of cardiac markers. Scand J Clin Lab Invest 2001, 61:95-102.
37. Banerjee S., Linder M.W., Singer I. False-positive troponin I in a patient with acute cholecystitis and positive rheumatoid factor assay. Cardiology 2001, 95:170-171.
38. Kim W.J., Laterza O.F., Hock K.G., et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002, 48:1028-1034.
39. Panteghini M. A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins. Clin Chem Lab Med 2009, 47:1179-1182.